InnoCan Pharma
(OTC) INNPF
InnoCan Pharma Financials at a Glance
Market Cap
$19.79M
Revenue (TTM)
$26.61M
Net Income (TTM)
$1.12M
EPS (TTM)
$-0.25
P/E Ratio
-17.56
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Price
$4.40
Volume
100
Open
$4.40
Price
$4.40
Volume
100
Open
$4.40
Previous Close
$4.40
Daily Range
$4.40 - $4.40
52-Week Range
$0.13 - $14.26
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Price
$4.40
Volume
100
Open
$4.40
Previous Close
$4.40
Daily Range
$4.40 - $4.40
52-Week Range
$0.13 - $14.26
INNPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout InnoCan Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
9
CEO
Iris Or Gabi Bincovich
Website
www.innocanpharma.comHeadquarters
Calgary, AB T2P 0N7, CA
INNPF Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-21%
Return on Capital
-14%
Return on Assets
-11%
Earnings Yield
-5.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.79M
Shares Outstanding
4.50M
Volume
100
Avg. Volume
211.919
Financials (TTM)
Gross Profit
$23.93M
Operating Income
$1.25M
EBITDA
$130.00K
Operating Cash Flow
$495.00K
Capital Expenditure
$16.00K
Free Cash Flow
$479.00K
Cash & ST Invst.
$6.69M
Total Debt
$930.00K
InnoCan Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.06M
-6.2%
Gross Profit
$4.50M
+2.0%
Gross Margin
88.84%
N/A
Market Cap
$19.79M
N/A
Market Cap/Employee
$1.80M
N/A
Employees
11
N/A
Net Income
$1.97M
+1831.1%
EBITDA
$1.59M
+13110.4%
Quarterly Fundamentals
Net Cash
$5.76M
+15.2%
Accounts Receivable
$944.00K
+37.7%
Inventory
$2.18M
-34.3%
Long Term Debt
$930.00K
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-10.68%
N/A
Return on Invested Capital
-13.69%
N/A
Free Cash Flow
$587.00K
-15.6%
Operating Cash Flow
$581.00K
-15.3%